Clinical Trials Browser

Phase 2 × Iohexol × 30 days × Clear all

NCT06820320 2026-03-06

Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy

Phase 2 Completed

Abdominal Neoplasms, Chylous Ascites, Pelvic Neoplasms